38
Participants
Start Date
February 13, 2019
Primary Completion Date
February 16, 2023
Study Completion Date
February 16, 2023
IBI101
0.01 mg/kg; 0.1 mg/kg; 0.3 mg/kg; 1 mg/kg; 3 mg/kg; 6 mg/kg; 10 mg/kg; 15 mg/kg iv infusion day 1 of every 21 days
IBI101
1 mg/kg; 3 mg/kg; 6 mg/kg; 10 mg/kg iv infusion day 1 of every 21 days
Sintilimab
200mg iv infusion day 1 of every 21 days
Sun Yat-sen University Cancer Center, Guangzhou
Innovent Biologics (Suzhou) Co. Ltd.
INDUSTRY